No-Cholesterol Capsules Ingredients — Every Herb Explained

No-Cholesterol Capsules Ingredients — Every Herb Explained

By Wow Herbs Team | Updated: July 2026 | 9 min read

Every herb in a well-formulated supplement should earn its place — with identifiable active compounds, understood mechanisms, and research supporting its specific contribution. This guide provides a complete breakdown of the key herbs in No-Cholesterol Capsules, explaining what each does, how it works at the molecular level, and why it belongs in a comprehensive natural cholesterol management formula.

Garlic (Allium sativum) — The Cardiovascular Cornerstone

Active compounds: Allicin (produced from alliin + alliinase upon crushing), ajoene, S-allylcysteine (SAC), S-allylmercaptocysteine (SAMC), diallyl disulphide (DADS), flavonoids, selenium.

Processing note: Allicin — garlic's primary active compound — is not present in the raw clove. It is produced when the enzyme alliinase (released from damaged cells) converts alliin into allicin. Crushing or cutting activates this reaction. Quality supplements use either aged garlic extract (rich in SAC) or allicin-standardised extract.

Mechanisms for cholesterol management:

HMG-CoA reductase inhibition: SAC and ajoene demonstrate inhibitory activity on HMG-CoA reductase — the rate-limiting enzyme in hepatic cholesterol synthesis. This is the same enzymatic target as pharmaceutical statins, achieved through natural compounds with a gentler pharmacological profile.

Increased bile acid excretion: Garlic compounds increase the conversion of hepatic cholesterol into bile acids — promoting cholesterol elimination through the digestive tract.

Antioxidant LDL protection: SAC and selenium in aged garlic extract provide significant antioxidant protection against LDL oxidation — addressing the critical step between elevated LDL and actual plaque formation.

Platelet aggregation inhibition: Ajoene is one of the most potent natural platelet aggregation inhibitors identified — reducing thrombotic risk independently of its lipid effects.

Clinical evidence: A meta-analysis published in the Journal of Nutrition analysing 39 randomised controlled trials found that garlic supplementation produced significant reductions in total cholesterol (average 17 mg/dL) and triglycerides, with modest effects on LDL — across multiple populations and garlic preparation types.

Unani classification: Mufatteh (aperient), mudir (promoter of circulation), mufarreq (dispersant of thick blood), muhallil (anti-inflammatory).

Fenugreek (Trigonella foenum-graecum) — The Bile Acid Binder

Active compounds: Steroidal saponins (diosgenin, yamogenin, tigogenin), 4-hydroxyisoleucine, galactomannan fibre, alkaloids (trigonelline), flavonoids.

Mechanisms for cholesterol management:

Bile acid sequestration via galactomannan: Fenugreek's galactomannan — a viscous soluble fibre — forms a gel in the small intestine that binds bile acids and prevents their reabsorption. The liver draws LDL cholesterol from circulation to replace the excreted bile acids — directly reducing LDL.

Diosgenin and intestinal cholesterol absorption: Diosgenin — fenugreek's primary steroidal saponin — competitively inhibits the Niemann-Pick C1-like 1 (NPC1L1) transporter in the intestinal wall — the same transporter blocked by the pharmaceutical ezetimibe. This inhibition directly reduces dietary cholesterol absorption.

4-Hydroxyisoleucine and insulin sensitivity: By improving insulin sensitivity, fenugreek reduces the hyperinsulinaemia that drives excess hepatic VLDL and triglyceride synthesis — indirectly improving triglycerides and LDL particle number.

Clinical evidence: A study published in the European Journal of Clinical Nutrition found fenugreek supplementation significantly reduced total cholesterol (by 14%), LDL (by 25%), and triglycerides (by 11%) while increasing HDL by 10% over 8 weeks — one of the most comprehensive lipid profile improvements demonstrated by any single herbal supplement.

Psyllium Husk (Plantago ovata) — The Fibre Powerhouse

Active compounds: Arabinoxylan (primary — highly viscous soluble fibre, 70% of husk weight), mucilage polysaccharides, phenolic compounds.

Why it stands apart: Psyllium husk has one of the most rigorously demonstrated cholesterol-lowering effects of any dietary fibre — earning formal health claim approval from multiple regulatory bodies including the FDA for its role in reducing cardiovascular disease risk.

Mechanisms:

Superior bile acid binding: Psyllium's arabinoxylan forms an exceptionally viscous gel — more viscous than most other soluble fibres — that effectively traps bile acids in the intestinal lumen, preventing their reabsorption. This is the primary mechanism of its LDL-lowering effect.

Cholesterol absorption reduction: The viscous gel also forms a physical barrier to intestinal cholesterol absorption — reducing the dietary cholesterol contribution to LDL levels.

Microbiome modification: Psyllium is fermented by specific gut bacteria to produce short-chain fatty acids — particularly propionate, which inhibits hepatic cholesterol synthesis through effects on HMG-CoA reductase.

Clinical evidence: A meta-analysis published in the American Journal of Clinical Nutrition analysing 21 controlled trials found psyllium supplementation reduced LDL cholesterol by an average of 8% — consistent across populations and dietary backgrounds. The FDA has approved the claim: "Soluble fibre from foods such as psyllium husk, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease."

Turmeric (Curcuma longa) — The Anti-Inflammatory Protector

Active compounds: Curcuminoids (curcumin 77%, demethoxycurcumin 17%, bisdemethoxycurcumin 3%), volatile oils.

Mechanisms for cardiovascular and cholesterol health:

Anti-inflammatory atherosclerosis prevention: Curcumin's potent NF-κB inhibitory activity reduces the production of pro-inflammatory cytokines (TNF-alpha, IL-1β, IL-6) that drive the inflammatory component of atherosclerotic plaque development. By reducing arterial wall inflammation, curcumin addresses cardiovascular risk at a level beyond simple cholesterol management.

LDL receptor upregulation: Research has found curcumin upregulates hepatic LDL receptor expression — increasing the liver's capacity to clear LDL from circulation. This mechanism mirrors the effect of some pharmaceutical cholesterol-lowering agents.

Antioxidant LDL protection: Curcumin's free radical scavenging activity prevents LDL oxidation — the critical step converting elevated LDL from a risk factor into an active atherogenic agent.

Triglyceride reduction: Curcumin inhibits fatty acid synthase — reducing hepatic triglyceride synthesis — and supports hepatic lipase activity that clears VLDL triglycerides from circulation.

Clinical evidence: A meta-analysis of 7 randomised controlled trials found curcumin supplementation significantly reduced total cholesterol, LDL cholesterol, and triglycerides while increasing HDL — consistent with multiple independent mechanisms addressing the lipid profile comprehensively.

Cinnamon — Ceylon (Cinnamomum verum) — The Metabolic Regulator

Active compounds: Methylhydroxychalcone polymer (MHCP), cinnamaldehyde, procyanidins, cinnamic acid.

Mechanisms for lipid management:

Insulin receptor activation: MHCP activates insulin receptors — improving cellular insulin sensitivity. This reduces the hyperinsulinaemia that drives excess VLDL and triglyceride synthesis in the liver.

HMG-CoA reductase modulation: Cinnamon proanthocyanidins have demonstrated inhibitory effects on HMG-CoA reductase — reducing hepatic cholesterol biosynthesis.

Anti-glycation: Cinnamon compounds inhibit protein glycation — reducing the formation of glycated LDL, which is more atherogenic than standard LDL and is poorly cleared by normal LDL receptors.

Clinical evidence: A meta-analysis of 10 RCTs found cinnamon supplementation significantly reduced total cholesterol, LDL, and triglycerides — with the most pronounced effects in those with type 2 diabetes or metabolic syndrome, where insulin resistance is driving lipid abnormalities.

Ginger (Zingiber officinale) — The Lipid-Modifying Root

Active compounds: Gingerols (6-gingerol primary), shogaols, paradols, zingerone, volatile oils.

Mechanisms for cholesterol management:

HMG-CoA reductase inhibition: 6-gingerol and 6-shogaol demonstrate HMG-CoA reductase inhibitory activity — reducing the rate of hepatic cholesterol biosynthesis through the primary regulatory enzyme in the cholesterol synthesis pathway.

Increased bile acid synthesis: Ginger significantly increases the conversion of hepatic cholesterol into bile acids — promoting cholesterol elimination and lowering circulating cholesterol levels. Research has found ginger increases the activity of cholesterol 7-alpha hydroxylase — the rate-limiting enzyme in bile acid synthesis from cholesterol.

Antioxidant LDL protection: Gingerols and shogaols are potent antioxidants that prevent LDL oxidation — specifically reducing the formation of oxidised LDL that initiates plaque formation.

Clinical evidence: A double-blind randomised controlled trial published in Phytotherapy Research found ginger supplementation (3g daily for 45 days) significantly reduced triglycerides, total cholesterol, LDL, and VLDL compared to placebo in hyperlipidaemic patients — with the researchers attributing effects to the combined HMG-CoA inhibitory and bile acid synthesis mechanisms.

Black Seed (Nigella sativa) — The Multifunctional Cardiovascular Herb

Active compounds: Thymoquinone (TQ, 30-48% of volatile oil), thymohydroquinone, dithymoquinone, fixed oils (linoleic acid, oleic acid), phytosterols.

Mechanisms:

Lipid profile improvement: TQ has demonstrated multiple lipid-modifying effects — reducing total cholesterol, LDL, and triglycerides while increasing HDL. The mechanisms include: reduced hepatic cholesterol synthesis, increased bile acid excretion, and antioxidant protection of HDL particles.

Anti-inflammatory atherosclerosis prevention: TQ's NF-κB inhibitory anti-inflammatory activity complements curcumin's anti-inflammatory action — both addressing the inflammatory dimension of atherosclerosis through related but distinct molecular pathways.

Phytosterol content: Black seed oil contains significant phytosterols that competitively inhibit intestinal cholesterol absorption — reducing the dietary cholesterol contribution to LDL levels.

Clinical evidence: A systematic review of 17 clinical trials found black seed supplementation consistently improved lipid profiles — reducing total cholesterol, LDL, and triglycerides while increasing HDL across diverse populations.

How the Ingredients Work Together — The Synergy

No-Cholesterol's formula addresses cholesterol through four distinct pathways simultaneously:

Pathway 1 — Reduced cholesterol synthesis: Garlic (SAC/HMG-CoA), ginger (HMG-CoA), cinnamon (proanthocyanidins/HMG-CoA)

Pathway 2 — Reduced cholesterol absorption: Fenugreek (galactomannan + diosgenin/NPC1L1), psyllium (arabinoxylan gel)

Pathway 3 — Increased cholesterol elimination: Psyllium (bile acid sequestration), fenugreek (bile acid sequestration), ginger (bile acid synthesis upregulation)

Pathway 4 — Cardiovascular protection beyond numbers: Turmeric (NF-κB anti-inflammatory, LDL receptor upregulation), black seed (TQ antioxidant + anti-inflammatory), garlic (platelet aggregation inhibition)

This four-pathway, seven-herb approach is why No-Cholesterol produces more comprehensive lipid management than any single herb — each addressing a distinct point in cholesterol metabolism or cardiovascular risk.

Frequently Asked Questions

Are these ingredients safe alongside statin medication?

Most ingredients have good compatibility with statin medication. Garlic has mild anticoagulant properties — relevant if also on blood-thinning medication. Ginger may mildly enhance statin bioavailability in some cases. Always inform your GP about all supplements you take alongside prescribed medication.

Do the ingredients contain any animal products?

No — every ingredient is plant-derived. HPMC vegetarian capsule shell. Fully vegan and halal suitable.

Can these ingredients lower cholesterol without dietary changes?

The ingredients produce meaningful cholesterol management effects with or without dietary changes — but dietary modification significantly amplifies their impact. Reducing saturated fat, trans fat, and refined carbohydrates while increasing dietary fibre and plant foods produces synergistic improvement when combined with No-Cholesterol's herbal mechanisms.

Conclusion

No-Cholesterol's ingredient profile represents a carefully constructed multi-herb formula where each plant contributes a distinct and complementary mechanism to comprehensive cholesterol management — addressing synthesis, absorption, elimination, and vascular protection simultaneously.

→ Shop No-Cholesterol Capsules at Wow Herbs

Related: No-Cholesterol Capsules Benefits | Natural Cholesterol Guide

Disclaimer: For informational purposes only. Consult your GP before starting any supplement.